Vonoprazan-based Therapy Versus Standard Regimen for Helicobacter Pylori Infection Management
Helicobacter Pylori Infection
About this trial
This is an interventional treatment trial for Helicobacter Pylori Infection focused on measuring Helicobacter Pylori, vonoprazan, standard triple therapy
Eligibility Criteria
Inclusion Criteria: Patients with positive stool antigen test result for H. pylori Patients recently diagnosed with H. pylori infection and did not receive any treatment Exclusion Criteria: Patients sensitive to any of the regimens' components Patients who had received a previous eradication therapy and still show positive test results Recent use of antimicrobial agents, proton pump inhibitors, and H2 receptor blockers within 1 month Patients with gastric malignancy or who underwent previous gastric surgery Pregnancy and lactation Patients with major concomitant diseases, including psychic disorders
Sites / Locations
- Alexandria University outpatient clinicsRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Experimental
Experimental
S3
V3
V2
Standard clarithromycin triple
Vonoprazan triple
Vonoprazan dual